出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2009年第7期623-627,共5页
Cancer Research on Prevention and Treatment
基金
云南省教育厅科研基金资助项目(08J0022)
参考文献48
-
1Calvert PM, Frucht H. The genetics of colorectal cancer[J]. Ann Intern Med, 2002,137(7) : 603-612.
-
2Troppmair J, Bruder JT, Munoz H, et al. Mitogen-activated protein kinase extraeellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradeeanoylphorbol- 13-acetate requires Raf and is necessary for transformation[J]. J Biol Chem, 1994,269(9) :7030-7035.
-
3Taupin D,Podolski DK. Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation[J]. Gastroenterology, 1999,116(5) : 1072-1080.
-
4Liu WS, Heckman CA. The sevenfold way of PKC regulation [J]. Cell Signal, 1998,10 (8) : 529-542.
-
5Chen DB,Davis JS. Epidermal growth factor induces c-los and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -independ- ent pathways in bovine luteal cells[J]. Mol Cell Endocrinol, 2003,200(1-2) : 141-154.
-
6Sato S,Fujita N,Tsuruo T. Involvement of PDK1 in the MEK/ MAPK signal-transduction pathwayEJ-. J Biol Chem,2004,279 (32) : 33759-33767.
-
7Crew CM,Alessandrini A, Erikson RL. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product[J].Science,1992,258(5081):478-480.
-
8Khokhlatchev AV, Canagarajah B, Wilsbacher J, et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear transloeation[J]. Cell, 1998, 93 (4) : 605- 615.
-
9Lavoie JN,L'Allemain G,Brunet A,et al. Cyelin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway [J].J Biol Chem, 1996, 271 (34) :20608-20616.
-
10Woods D, Parry D, Cherwinski H, et al. Raf-1 induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21^Cip1 [J]. Mol Cell Biol, 1997,17 (9):98-5611.
二级参考文献10
-
1Jemal A,Siegel R,Ward E,Murray T,Xu J,Smigal C, etal.Cancerstatistics,2006[].CACancerJClin.2006
-
2Todd W Bauer MD,Fan Fan,BS,et al.Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cellsrequires activation of c-met and urokinase plasminogen activator re-ceptor[].Annals of Surgery.2005
-
3Kaio E,Tanaka S,Kitadai Y,Sumii M,Yoshihara M,Haruma K,Chayama K.Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma[].Oncology.2003
-
4Carmeliet P,Jain R K.Angiogenesis in cancer and other diseases[].Nature.2000
-
5Takahashi Y,Kitadai Y,Bucana CD,Cleary KR,Ellis LM.Expression of vascular endothelial growth factor and its receptor,KDR,correlates with vascularity,metastasis,and proliferation of human colon cancer[].Cancer Research.1995
-
6Leung, D.W,Cachianes, G,Kuang, W.J,Goeddel, D.V,Ferrara, N.Vascular endothelial growth factor is a secreted angiogenic mitogen[].Science.1989
-
7Senger,DR,Galli,SJ,Dvorak,AM,Perruzzi,CA,Harvey,VS,Dvorak,HF.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[].Science.1983
-
8Cooke,SP,Boxer,GM,Lawrence,L,Pedley,RB,Spencer,DIR,Begent,RHJ,Chester,KA.A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex[].Cancer Research.2001
-
9Slomiany MG,Black LA,Kibbey MM,et al.IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma[].Biochemical and Biophysical Research Communications.2006
-
10Calza,L,Giardino,L,Giuliani,A,Aloe,L,Levi-Montalcini,R.Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors[].Proceedings of the National Academy of Sciences of the United States of America.2001
共引文献12
-
1雷海鸣,卞建民.肝癌细胞中PI3K信号通路对VEGF表达的影响[J].现代肿瘤医学,2009,17(8):1432-1434. 被引量:3
-
2许志亮,孟妍妍,崔西龙,张申起,徐闻博,林国立.乳腺癌微淋巴管形成因素的研究进展[J].临床外科杂志,2009,17(7):494-495.
-
3郭运生.大肠癌组织中PI3K、Akt和HGF的表达变化及意义[J].山东医药,2010,50(46):77-78. 被引量:1
-
4祁慧薇,范理宏.PI3K/Akt/mTOR信号转导通路与非小细胞肺癌[J].中国肺癌杂志,2010,13(12):1149-1154. 被引量:21
-
5肖秀英,于宝华.PI3K/Akt信号传导通路及其在结直肠癌中的研究进展[J].临床肿瘤学杂志,2011,16(6):558-561. 被引量:5
-
6玄香兰,安昌善,周彩存.肝细胞生长因子诱导敏感非小细胞肺癌细胞对吉非替尼耐药及机制的研究[J].中国肺癌杂志,2013,16(1):1-6. 被引量:16
-
7杨琨,何葵,李鹏,薛文,粱路昌.咖啡酸苯乙酯对人结肠癌PI3K/AKT信号通路的影响[J].社区医学杂志,2013,11(6):1-3. 被引量:2
-
8张洽,陆建波.恶性肿瘤信号通路的研究进展[J].肿瘤基础与临床,2014,27(2):178-182. 被引量:5
-
9刘华,刘勇,王艳,杨培,钱立庭.PI3K蛋白在食管鳞癌中的表达与临床意义[J].安徽医学,2016,37(2):184-186.
-
10玄香兰,张佳,安昌善.HGF诱导不同EGFR基因型非小细胞肺癌细胞对厄洛替尼的耐药[J].中国肿瘤生物治疗杂志,2014,21(4):413-418. 被引量:1
同被引文献17
-
1射干根茎提取物质有助治疗前列腺癌[J].世界科学技术-中医药现代化,2009,11(3):406-406. 被引量:2
-
2覃裕露,赵杨,申兴斌.EGF、EGFR、C-erbB-2在恶性肿瘤中的研究进展[J].承德医学院学报,2012,29(2):182-185. 被引量:11
-
3王丹,康健.中药剂量与药效的相关性研究[J].河南中医,2013,33(7):1158-1159. 被引量:10
-
4刘明开,王辉,于晶功,王乙,刘日旭,高鹏.PI3K和VEGF在大肠癌中的表达及意义[J].实用检验医师杂志,2013,5(3):175-178. 被引量:1
-
5陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
-
6胡丽娟.加味左金丸对大肠癌裸鼠ERK/MAPK信号通路的干预作用[J].新中医,2015,47(2):230-232. 被引量:5
-
7邱雪梅,马超英.槲皮素抗结肠癌的研究进展[J].中华中医药学刊,2015,33(10):2333-2335. 被引量:11
-
8陈典克,罗倩欣,俞希虎,甘肖勤,林溢恒,吴培煌,王磊.c-Jun基因启动子区多态性位点rs4646999与肠癌预后的相关性[J].实用医学杂志,2017,33(21):3518-3523. 被引量:6
-
9周晓黎,舒磊,彭随风,高晓阳,滕晓丽,杨家耀,时昭红.HIF-1α在低氧环境结肠癌细胞糖酵解中的作用[J].内科急危重症杂志,2017,23(5):379-383. 被引量:2
-
10刘成成,黄慧瑶,石菊芳,王乐,石春雷,何世娇,王征,郭春光,刘骞,代敏.我国1996~2015年结直肠癌经济负担的系统评价[J].中国肿瘤,2017,26(11):859-867. 被引量:22
引证文献2
-
1葛兴森,甘雨,陈贺,李国信,张宏,秦文艳.射干提取物对AOM/DSS诱导小鼠炎症相关性肠癌模型中MAPK及PI3K的影响[J].实用中医内科杂志,2023,37(1):29-31.
-
2潘雨烟,罗梦雪,方霜霜,徐楚楚,苏晓兰,魏玮.基于网络药理学的乌梅抗结直肠癌机制研究[J].海南医学院学报,2021,27(14):1084-1090. 被引量:6
二级引证文献6
-
1李熠,李琼玉,梁靖华.基于数据挖掘中药预防结肠息肉术后复发的用药规律[J].实用中医内科杂志,2021,35(10):36-38. 被引量:4
-
2朱月,袁静,孙文波,刘同亭.乌梅药理作用及临床应用研究进展[J].辽宁中医药大学学报,2022,24(7):155-159. 被引量:27
-
3马葳,田浩君,孙秀清,孙启胜,李鹏.健脾补肾止泻方结合西医常规疗法治疗糖尿病性腹泻脾肾阳虚证临床研究[J].国际中医中药杂志,2022,44(9):992-995. 被引量:2
-
4赵旦娅,郑浩,宋昌娟,卢海霞,曾树宏,刘婷,孙月婷,陆为民.徐氏抑肝扶脾方治疗肝郁脾虚证腹泻型肠易激综合征的临床研究[J].中华中医药杂志,2022,37(12):7491-7494. 被引量:3
-
5杨亚湉,王瑞,钱程程,吴瑞,欧金梅.乌梅化学成分、药理作用研究进展及质量标志物预测[J].中成药,2023,45(5):1583-1588. 被引量:27
-
6邢烙涛,陈思杨,甘秦汉,甘雪军,董芷辛,许梅,姚菲,方芳,石玮.寒温并用代表方乌梅丸治疗恶性肿瘤的研究进展[J].医学综述,2024,30(4):433-438.
-
1刘爱东.VEGF-C和Flt-4在大肠癌表达关系的研究[J].唐山职业技术学院学报,2009,7(4):65-67.
-
2刘国栋,刘晓.维生素D_3防治泌尿系肿瘤[J].现代泌尿外科杂志,2004,9(2):63-65.
-
3朱丹,王瑛坚,邱丹,刘莉.原发性卵巢上皮性恶性肿瘤中Livin和Fas的表达及相关性分析[J].中国实验诊断学,2014,18(8):1312-1314. 被引量:3
-
4宋姗姗,刘明华.血管内皮生长因子与肿瘤血管生成的研究进展[J].四川生理科学杂志,2010,32(4):167-169. 被引量:4
-
5结肠、直肠、肛门[J].中国医学文摘(外科学),2006,25(3):208-213.
-
6石小燕,李红雨,柳友清,马丁.VEGF-C及其受体flt-4在宫颈癌淋巴管生成及转移中的作用[J].中国肿瘤临床,2005,32(4):181-184. 被引量:7
-
7邓凤春,张鹏,李玉兰.VEGF-C/flt-4调控系统与宫颈癌淋巴管生成及转移关系的探讨[J].中国医疗前沿,2009,4(18):1-2. 被引量:3
-
8韩玉,惠汝太.影响结肠癌与血管生成的细胞因子[J].中国分子心脏病学杂志,2006,6(2):119-126. 被引量:1
-
9王维平,裘明德.血管内皮生长因子与脑肿瘤的研究进展[J].医学临床研究,2007,24(12):2136-2138. 被引量:1
-
10郭宗梁,张林燕.微小核糖核酸与宫颈癌的研究进展[J].中国医药,2014,9(1):133-135. 被引量:2